Skip to Content
Merck
  • Targeting glycolysis: a fragment based approach towards bifunctional inhibitors of hLDH-5.

Targeting glycolysis: a fragment based approach towards bifunctional inhibitors of hLDH-5.

Chemical communications (Cambridge, England) (2010-08-03)
Adam D Moorhouse, Christian Spiteri, Pallavi Sharma, Mire Zloh, John E Moses
ABSTRACT

hLDH-5 has emerged as a promising target for anti-glycolytic cancer chemotherapy. Here we report a first generation of bifunctional inhibitors, which show promising activity against hLDH-5.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Oxamic acid, ≥98%